Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TIMP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
P2RX4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF4EBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLIPR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC2A4RG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MMP16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC01234 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
C16orf59 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPRM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HMMR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKLE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
METTL7A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPAT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2N - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STAT4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C3orf14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on